Abstract
The effects of the 5-HT 2A/2C receptor antagonist, ketanserin, and the 5-HT 2C receptor antagonist, SB 206553, on lordosis behavior were investigated in ovariectomized rats hormonally primed with estradiol benzoate (EB) (0.5 or 25 μg) and progesterone (500 μg). Both ketanserin and SB 206553 inhibited lordosis behavior after infusion into the ventromedial nucleus of the hypothalamus (VMN), but ketanserin was slightly more effective than the 5-HT 2C receptor antagonist. Either drug was more effective in rats primed with 0.5 μg EB than in rats hormonally primed with 25 μg EB. These findings support the suggestion that estrogen may enhance functioning of the 5-HT 2 receptor family and thereby protect against the 5-HT 2 receptor antagonists. These data are consistent with prior suggestions that estrogen modulates functioning of 5-HT 2 receptors within the VMN and that 5-HT 2 receptors play a facilitatory role in the modulation of female rat lordosis behavior.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
